Posts Tagged 'breast cancer'

Mass. women at trial: Pregnancy drug caused cancer

Eli Lilly and Co. failed to test the effects of the drug DES, or diethylstilbestrol on fetuses before promoting it as a way to prevent miscarriages, a lawyer charged Tuesday in opening statements in a trial over whether four sisters’ breast cancer was caused by medication their mother took during pregnancy in the 1950s.

Read more about the link between DES and breast cancer…

FDA revokes approval of Avastin for breast cancer

The U.S. Food and Drug Administration has declared the blockbuster drug Avastin should no longer be used in breast cancer patients because there is no proof it extends their lives — and it is causing dangerous side effects.

Click here to read more…

Silicone is safe, FDA says (besides, options are few)

The Food and Drug Administration is essentially telling U.S. consumers worried about silicone breast implants: “Told you so.” But in releasing new research backing up its 2006 decision to allow the implants back onto the market, the agency also reminds women, in a way, that they have only two choices — silicone or saline. Until 2006, silicone implants had been under a 14-year ban by the FDA because of concerns that leaks or ruptures could increase the risk of certain diseases.

Click here to read more…

Timing, Type of HRT May Determine Breast Cancer Risk

The timing and type of hormone replacement therapy women take to relieve menopausal symptoms seem to determine the degree of breast cancer risk they face, a new French study suggests. Overall, starting estrogen-progestagen therapy soon after menopause appears to boost the risk of breast cancer, even when only used for short periods of time. Women who began the therapy in the three years after menopause and took it for two years or less had a 54 percent higher risk of breast cancer compared to those who never used the therapy.

Click here to read more…

Breast cancer ‘wonder drug’ increases risk of rare tumour by 440%

Breast cancer patients given tamoxifen are more than four times more likely to develop a more aggressive tumour than those not prescribed the drug, scientists have warned. A study of over 1,000 patients found the oestrogen blocking drug reduced the risk of the most common, easy to treat cancer recurring by 60 per cent. But the chances of a rarer type not sensitive to the female hormone appearing in the opposite breast increased by an alarming 440 per cent.

Click here to read more…


Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 437 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101

Email: info@hkllp.com

Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.